A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP).
Fiona J GiffordPhilip D J DunneGraeme WeirHamish IrelandCatriona GrahamSharon TuckPeter C HayesJonathan Andrew FallowfieldPublished in: Trials (2020)
ClinicalTrials.gov, NCT02669875. Registered on 1 February 2016.